Tor-Björn Käll

648 total citations
9 papers, 249 citations indexed

About

Tor-Björn Käll is a scholar working on Pathology and Forensic Medicine, Epidemiology and Immunology. According to data from OpenAlex, Tor-Björn Käll has authored 9 papers receiving a total of 249 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Pathology and Forensic Medicine, 4 papers in Epidemiology and 3 papers in Immunology. Recurrent topics in Tor-Björn Käll's work include Multiple Sclerosis Research Studies (6 papers), T-cell and B-cell Immunology (3 papers) and Acute Ischemic Stroke Management (3 papers). Tor-Björn Käll is often cited by papers focused on Multiple Sclerosis Research Studies (6 papers), T-cell and B-cell Immunology (3 papers) and Acute Ischemic Stroke Management (3 papers). Tor-Björn Käll collaborates with scholars based in Sweden, United States and Germany. Tor-Björn Käll's co-authors include Jan Hillert, Olle Olerup, M. Söderström, Mia von Euler, Nils Wahlgren, Christina Sjöstrand, Annika Berglund, Lars Engerström, Leif Svensson and S. Fredrikson and has published in prestigious journals such as PLoS ONE, Stroke and Journal of Internal Medicine.

In The Last Decade

Tor-Björn Käll

9 papers receiving 241 citations

Peers

Tor-Björn Käll

EPIDE

PFM

NEURO

IMMUN

REHAB

Federica Casoni Italy

Pontus Harten Germany

Renata Miossi Brazil

José A. Roca Peru

Chris Douglass United Kingdom

Simon Winzer Germany

Bruno Barroso France

Haijiao Jing China

Tai‐Li Chen Taiwan

Helena Borrell Spain

Federica Casoni Italy

Tor-Björn Käll

112 ×1.1

EPIDE

35 ×0.5

PFM

76 ×1.1

NEURO

17 ×0.3

IMMUN

30 ×0.8

REHAB

Citations per year, relative to Tor-Björn Käll Tor-Björn Käll (= 1×) peers Federica Casoni

Countries citing papers authored by Tor-Björn Käll

Since Specialization

Citations

This map shows the geographic impact of Tor-Björn Käll's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tor-Björn Käll with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tor-Björn Käll more than expected).

Fields of papers citing papers by Tor-Björn Käll

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tor-Björn Käll. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tor-Björn Käll. The network helps show where Tor-Björn Käll may publish in the future.

Co-authorship network of co-authors of Tor-Björn Käll

This figure shows the co-authorship network connecting the top 25 collaborators of Tor-Björn Käll. A scholar is included among the top collaborators of Tor-Björn Käll based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tor-Björn Käll. Tor-Björn Käll is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

1.

Kostulas, Nikolaos, Martin Larsson, Tor-Björn Käll, Mia von Euler, & David Nathanson. (2017). Safety of thrombolysis in stroke mimics: an observational cohort study from an urban teaching hospital in Sweden. BMJ Open. 7(10). e016311–e016311. 19 indexed citations

2.

Wahlgren, Nils, M. Thorén, Tor-Björn Käll, et al.. (2016). Randomized assessment of imatinib in patients with acute ischaemic stroke treated with intravenous thrombolysis. Journal of Internal Medicine. 281(3). 273–283. 47 indexed citations

3.

Berglund, Annika, Leif Svensson, Christina Sjöstrand, et al.. (2012). Higher Prehospital Priority Level of Stroke Improves Thrombolysis Frequency and Time to Stroke Unit. Stroke. 43(10). 2666–2670. 72 indexed citations

4.

Haghikia, Aiden, Bartosz Puła, Stephan Ruhrmann, et al.. (2011). Functional Energetics of CD4+-Cellular Immunity in Monoclonal Antibody-Associated Progressive Multifocal Leukoencephalopathy in Autoimmune Disorders. PLoS ONE. 6(4). e18506–e18506. 21 indexed citations

5.

Fredrikson, S., M. Söderström, Jan Hillert, et al.. (2009). Multiple sclerosis: occurrence of myelin basic protein peptide-reactive T cells in healthy family members. Acta Neurologica Scandinavica. 89(3). 184–189. 1 indexed citations

6.

Hillert, Jan, Tor-Björn Käll, Olle Olerup, & M. Söderström. (1996). Distribution of HLA-Dw2 in optic neuritis and multiple sclerosis indicates heterogeneity. Acta Neurologica Scandinavica. 94(3). 161–166. 14 indexed citations

7.

Hillert, Jan, et al.. (1994). The HLA-Dw2 haplotype segregates closely with multiple sclerosis in multiplex families. Journal of Neuroimmunology. 50(1). 95–100. 38 indexed citations

8.

Söderström, M., M. Lindqvist, Jan Hillert, Tor-Björn Käll, & Hans Link. (1994). Optic neuritis: findings on MRI, CSF examination and HLA class II typing in 60 patients and results of a short-term follow-up. Journal of Neurology. 241(6). 391–397. 32 indexed citations

9.

Hillert, Jan, Tor-Björn Käll, & Olle Olerup. (1993). HLA-Dw2 in multiple sclerosis: A world-wide association and a close segregation with disease in multiplex families. Human Immunology. 36(1). 50–50. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact